WebMercator MedSystems has raised a total of $23.3M in funding over 4 rounds. Their latest funding was raised on Jun 13, 2024 from a Series D round. Mercator MedSystems is funded by 6 investors. Shenzhen Salubris Pharmaceuticals and Aphelion Capital are the most recent investors. Web26 apr. 2024 · EMERYVILLE, Calif., April 26, 2024 /PRNewswire-USNewswire/ -- Mercator MedSystems, Inc., a medical technology company, announced today the first patient enrollment into the TANGO (Temsirolimus ...
Global Renal Denervation Devices Market $5.6 Billion by 2029
WebMercator MedSystems. Private Company. Founded 2000. USA. Mercator MedSystems, Inc., is a medical technology company focused on the treatment of peripheral artery disease using its catheter-guided, micro-infusion systems for site-specific, ... Web25 jun. 2024 · Assignee: MERCATOR MEDSYSTEMS, INC. Inventors: Kirk Patrick Seward, Isidro M. Gandionco, David Gandionco Ultrasound-based neuromodulation system Patent number: 10456605 Abstract: A neuromodulation system including a catheter has a balloon along its distal end. jessica bryant instagram
510(k) Notification - Food and Drug Administration
Web26 apr. 2024 · EMERYVILLE, Calif., April 26, 2024 /PRNewswire-USNewswire/ -- Mercator MedSystems, Inc., a medical technology company, announced today the first patient enrollment into the TANGO (Temsirolimus Adventitial Delivery to Improve Angiographic Outcomes Below the Knee) clinical trial. TANGO will study the effects of using … Web19 jan. 2024 · The global market for renal denervation devices estimated to reach $5.6 billion by 2029, expanding at a double-digit CAGR of 27.5% over the forecast period, driven by increasing prevalence of treatment-resistant hypertension, and increasing demand for minimal invasive procedures worldwide. Web21 jun. 2024 · Mercator MedSystems, Inc. is a medical technology company focused on the treatment of peripheral artery disease utilizing its catheter-guided, microfluid infusion … jessica bruder bio